Company intelligence / Profile preview

Pro Zoon Pharma

Munich, Germany

Ownership: Private
Development stage: Other

Overview

ProZoon Pharma is a German biotechnology company focused on the development of innovative therapeutic solutions for zoonotic diseases. The company specializes in identifying and developing drug candidates that target pathogens capable of jumping from animals to humans, addressing a critical gap in global health security. Their research primarily involves small molecule and peptide-based approaches to combat emerging viral and bacterial threats. ProZoon Pharma aims to bridge the gap between veterinary medicine and human healthcare through a 'One Health' approach to drug discovery.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Pro Zoon Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro Zoon Pharma.

Explore the full profile